Genitourinary Radiology: Page 8

Blue Earth touts clinical results

By AuntMinnie.com staff writers

Blue Earth Diagnostics is highlighting results from a clinical study that has investigated the efficacy of the PET imaging agent F-18 rhPSMA-7.3 for detecting recurrent prostate cancer.

April 30, 2023

Avenda reaches milestone with Unfold AI software

By AuntMinnie.com staff writers

Artificial intelligence (AI) software developer Avenda Health said that its Unfold AI prostate cancer management platform has been used for the first time in a commercial setting.

April 27, 2023

Use of both iodine- and gado-based contrast boosts kidney injury risk

By Kate Madden Yee

Patients who present in the emergency department (ED) and undergo advanced CT and MR imaging with both iodine- and gadolinium-based contrast are at higher risk of postcontrast acute kidney injury (PC-AKI).

April 27, 2023

AUA, SUO issue guideline for prostate cancer detection

By AuntMinnie.com staff writers

The American Urological Association (AUO) and the Society of Urologic Oncology (SUO) have issued a 2023 clinical practice guideline on the early detection of prostate cancer.

April 25, 2023

New MRI technique helps target ultrasound-guided prostate biopsy

By Kate Madden Yee

A new microstructure imaging technique, hybrid multidimensional MRI (HM-MRI), could enable better targeting of areas in the prostate that need to be biopsied, according to a presentation at the American Roentgen Ray Society annual meeting in Honolulu.

April 23, 2023

SNMMI highlights prostate cancer study

By AuntMinnie.com staff writers

A recent study highlighted by the Society for Nuclear Medicine and Molecular Imaging (SNMMI) presents a new PET scoring system for predicting whether prostate cancer patients will respond to treatment with lutetium-177 prostate-specific membrane antigen-617.

April 20, 2023

PET/CT key to imaging patients with prostate cancer

By Will Morton

PET/CT imaging with novel radiotracers has emerged over the past several years as a first-line approach for diagnosing and monitoring treatments in patients with prostate cancer, according to an April 16 presentation at ARRS 2023 in Honolulu, HI.

April 18, 2023

Racial disparities persist in genitourinary clinical trials

By Will Morton

Racial disparities persist in genitourinary clinical trials of new biologic drugs and PET imaging radiotracers, according to a study published April 13 in Current Problems in Cancer.

April 16, 2023

Advantis gets FDA clearance for MRI analysis software

By AuntMinnie.com staff writers

Imaging software developer Advantis Medical Imaging has garnered U.S. Food and Drug Administration (FDA) clearance for its Advantis Platform brain and prostate MRI analysis software.

April 13, 2023

PET tracer for prostate cancer performs well in phase III trial

By Will Morton

PET/CT imaging with F-18 PSMA-1007 detects significantly more prostate cancer than imaging using the standard F-18 fluorocholine radiotracer, according to clinical results published in the April issue of the Journal of Nuclear Medicine.

April 13, 2023

MRI-targeted biopsy finds clinically significant prostate cancers

By Kate Madden Yee

MRI-targeted biopsy prompted by elevated prostate-specific antigen (PSA) levels identifies fewer clinically insignificant prostate cancers than systemic biopsy, according to a paper published April 4 in the Annals of Internal Medicine.

April 5, 2023

HistoSonics highlights first patient treated in CAIN trial

By AuntMinnie.com staff writers

HistoSonics has announced that the first kidney cancer patient has been treated in Leeds, U.K., using the company's histotripsy platform.

March 29, 2023

Previous Page

Page 8 of 93

Next Page